Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Cynthia Steimle

Thoracic Surgery (Cardiothoracic Vascular Surgery) Elgin, IL Medical Doctor

NPI 1285699512 CMS profile 1025509

1600 N Randall Rd Ste 355, Elgin, IL 60123

Open in the dashboard

General payments

$35,823

50 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cynthia Steimle of Elgin, IL is reported in the CMS Open Payments database as having received $35,823 across 50 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,022 5
2024 General $5,078 3
2023 General $4,886 4
2022 General $4,971 4
2021 General $6,524 14
2020 General $4,913 7
2019 General $4,429 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cynthia Steimle
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Cynthia Steimle were reported at $5,022. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Cynthia Steimle Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,429 $886 $178–$3,167 $163
2020 $4,913 $341 $108–$1,605 $114
2021 $6,524 $453 $125–$1,886 $132
2022 $4,971 $695 $180–$2,566 $149
2023 $4,886 $745 $205–$2,662 $160
2024 $5,078 $799 $214–$2,967 $164
2025 $5,022 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $33,354 9 payments
  2. Intuitive Surgical, Inc. $1,543 4 payments
  3. Organogenesis Inc. $256 14 payments
  4. MIMEDX Group, Inc. $148 1 payment
  5. Abbott Laboratories $133 1 payment
  6. Boston Scientific Corporation $86 4 payments
  7. E.R. Squibb & Sons, L.L.C. $84 5 payments
  8. Medtronic Vascular, Inc. $76 4 payments
  9. Janssen Pharmaceuticals, Inc $45 3 payments
  10. Tactile Systems Technology Inc $25 2 payments
  11. Other $72 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $19,453 5 payments
  2. Education $15,353 4 payments
  3. Food and Beverage $1,011 40 payments
  4. Travel and Lodging $6 1 payment
Products named General payments · program years 2019–2025
  1. VenaCure 1470 Pro Et $19,453 5 payments
  2. EVLT $9,053 2 payments
  3. VenaCure 1470 Pro Id $4,800 1 payment
  4. Da Vinci Surgical System $1,500 1 payment
  5. PERCLOSE PROGLIDE $133 1 payment
  6. Puraply $113 6 payments
  7. ELIQUIS $84 5 payments
  8. ClosureFast $76 4 payments
  9. VenaCure 1470 Pro Vit $48 1 payment
  10. XARELTO $45 3 payments
  11. Other $393 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

507

Median for Cardiac Surgery: 68

Drug cost

$48,594

Median for Cardiac Surgery: $445

Branded share of claims

18.7%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 30 $28,184
Xarelto Rivaroxaban Brand 15 $17,553
Ciprofloxacin Hcl Generic 25 $441
Metolazone Generic 13 $376
Triamcinolone Acetonide Generic 26 $329
Diltiazem Hcl Generic 21 $327
Tramadol Hcl Generic 157 $314
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 39 $264
Cephalexin Generic 24 $247
Prednisone Generic 86 $177

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$866,228

Medicare's payments for the services billed

Medicare patients

578

Average age 76

Services billed

4,548

351 women, 227 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 31%
Diabetes 26%
Chronic kidney disease 23%
Heart failure 21%
Atrial fibrillation 21%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

50 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record